Elantas Beck India closes trading window from July 1
Elantas Beck India Ltd has closed its trading window from July 1, 2026, until 48 hours after the Q1FY27 results announcement, adhering to SEBI insider trading regulations. The Board meeting date to approve the unaudited results for the quarter and half year ended June 30, 2026, is pending. Designated persons and insiders are prohibited from trading equity shares during this period.

*this image is generated using AI for illustrative purposes only.
Elantas Beck India Ltd has closed its trading window for designated persons, their immediate relatives, and other insiders effective July 1, 2026. This closure is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct. The restriction is implemented to regulate, monitor, and report trading in the company's securities during the period leading up to financial results.
The trading window will remain closed until 48 hours after the announcement or declaration of the unaudited financial results for the quarter and half year ending June 30, 2026. The company has stated that the specific date for the Board meeting to approve these results will be intimated in due course. All designated persons have been advised not to deal in the equity shares of the company during this closure period.
Key Details
| Parameter | Details |
|---|---|
| Trading Window Closure Start Date | July 1, 2026 |
| Reopening Date | 48 hours after Q1FY27 results announcement |
| Reporting Period | Quarter and half year ended June 30, 2026 |
| Regulatory Reference | SEBI (Prohibition of Insider Trading) Regulations, 2015 |
The communication was addressed to BSE Limited and signed by Ashutosh Bhanchandra Kulkarni, Head Legal & Company Secretary. The company has ensured that all relevant insiders are notified of the prohibition on trading activities during this specified timeframe.
Historical Stock Returns for Elantas Beck
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.08% | +13.81% | +17.54% | +14.74% | +14.74% | +14.74% |
What market expectations are forming regarding Elantas Beck's Q1 FY27 performance given the early trading window closure?
How might the upcoming Board meeting and results announcement impact the stock's volatility once the trading window reopens?
Are there any strategic initiatives or sector trends expected to influence the company's financial results for the quarter ending June 30, 2026?


































